在急性医院环境中进行预防性药物遗传测试:一个横截面研究
John H McDermott1,2, Kerry Burke2,3, Neil Fullerton1
1Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Oxford Road, Manchester, UK.
QJM : monthly journal of the Association of Physicians
|October 17, 2024
概括
在急性住院患者的基于小组的药物遗传学测试显示出高效率. 近14%的人经历了可操作的基因药物相互作用,年龄较大增加了风险,这凸显了对综合测试基础设施的需求.
科学领域:
- 药物基因组学 药物基因组学
- 临床药理学 临床药理学
- 遗传学 是一个遗传学.
背景情况:
- 药物遗传学指导的处方提高了药物的安全性和有效性.
- 实施策略因医疗保健系统和临床环境而异.
研究的目的:
- 在急性住院患者中评估基于小组的药物遗传学测试的临床实用性.
- 确定药物遗传测试对受益者的预测因素.
主要方法:
- 对急性住院患者的横截面研究.
- 基于小组的药物遗传学测试和基因药物相互作用的分析,基于住院患者的药物暴露.
- 后勤回归用于确定临床实用性的预测变量.
主要成果:
- 分析了482名住院患者 (平均年龄61.2岁);97.9%的人具有相关的药物遗传结果.
- 79.5%的患者接受了可用药物遗传学指导的药物.
- 13.7%的人有临床可行的基因药物相互作用;50岁以上的风险增加了2.7倍.
结论:
- 药物遗传学测试显示在急性医院环境中具有显著的潜力和临床实用性.
- 基础设施的发展对于支持医疗保健专业人员利用药物遗传检测至关重要.
- 测试可以确定可操作的基因药物相互作用,特别是在老年患者中.
相关概念视频
Analysis of Population Pharmacokinetic Data
237
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
237
Pharmacovigilance
783
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
783


